Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Pituitary Neoplasms 1Pituitary Diseases 1Insulin Resistance 1Dwarfism, Pituitary 1

Interventions

Metformin 12Exercise 6Inositol 4High-Intensity Interval Training 3Ethinyl Estradiol 3Water 2Preoperative Exercise 2Insulin 2Cyproterone Acetate 2Acupuncture Therapy 2ziprasidone 1exendin (9-39) 1drospirenone and ethinyl estradiol combination 1drospirenone 1adrenosterone 1Telemedicine 1Tablets 1Sugars 1Standard of Care 1Resistance Training 1Pioglitazone 1Phlebotomy 1Olanzapine 1Magnesium Oxide 1Magnesium 1Ketones 1Human Growth Hormone 1Health Planning Guidelines 1Growth Hormone 1Folic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Insulin Resistance × Human Growth Hormone × Clear all
NCT00518635 2013-02-20

Low Dose Growth Hormone in Obese PCOS Women

Oregon Health and Science University

Phase NA Withdrawn

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡